Skip to content

13F-HR filed by BRIDGER MANAGEMENT, LLC

BRIDGER MANAGEMENT, LLC filed this 13F-HR for the quarter ended 2018-03-31, filed 2018-05-15, with 37 holding rows worth $1,648,806,000.

Accession
0001166309-18-000005
Filed
2018-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2018

A holdings report, 37 entries on the cover page, a total value of $1,648,806,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,648,809,000 with VALUE read as thousands by filing date, 13F file number 028-10079. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
LABORATORY CORP OF AMERICA50540R409COM NEW614,622$99,415,000thousands by filing date
ATARA BIOTHERAPEUTICS INC COM NEW046513107Stock2,539,223$99,030,000thousands by filing date
GODADDY INC CL A380237107Stock1,496,992$91,945,000thousands by filing date
MEDICINES CO584688105COM2,657,486$87,538,000thousands by filing date
POST HLDGS INC737446104COM1,133,009$85,837,000thousands by filing date
NEKTAR THERAPEUTICS640268108COM668,492$71,034,000thousands by filing date
ZIMMER BIOMET HOLDINGS INC COM98956P102Stock642,652$70,075,000thousands by filing date
HUMANA INC COM444859102Stock254,246$68,349,000thousands by filing date
DEXCOM INC COM252131107Stock897,620$66,567,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock549,632$65,461,000thousands by filing date
ELDORADO RESORTS INC28470R102COM1,855,250$61,223,000thousands by filing date
Morgan Stanley617446448COM1,076,809$58,105,000thousands by filing date
MGM RESORTS INTERNATIONAL552953101COM1,523,332$53,347,000thousands by filing date
INCYTE CORP COM45337C102Stock622,152$51,844,000thousands by filing date
WRIGHT MED GROUP N VN96617118ORD SHS2,531,245$50,220,000thousands by filing date
WELLCARE HEALTH PLANS INC94946T106COM250,339$48,473,000thousands by filing date
CHARTER COMMUNICATIONS INC N16119P108COM140,460$43,714,000thousands by filing date
ARMSTRONG WORLD INDS INC NEW04247X102COM769,622$43,330,000thousands by filing date
VIASAT INC92552V100COM570,979$37,525,000thousands by filing date
HERON THERAPEUTICS INC427746102COM1,277,560$35,261,000thousands by filing date
SOMNIGROUP INTERNATIONAL INC COM88023U101Stock754,258$34,160,000thousands by filing date
TG THERAPEUTICS INC COM88322Q108Stock2,373,920$33,710,000thousands by filing date
LIBERTY BROADBAND A530307107COMMON STOCK390,292$33,097,000thousands by filing date
MSG NETWORK INC553573106CL A1,346,056$30,421,000thousands by filing date
ROCKET PHARMACEUTICALS INC77313F106COM1,578,569$29,598,000thousands by filing date
SCOTTS MIRACLE-GRO CO810186106CL A343,274$29,436,000thousands by filing date
Bank of America Corp060505104COM942,436$28,264,000thousands by filing date
META PLATFORMS INC CL A30303M102COM174,731$27,920,000thousands by filing date
WAVE LIFE SCIENCES LTD SHSY95308105Stock519,435$20,829,000thousands by filing date
Golden Entertainment Inc381013101Common Stock762,570$17,715,000thousands by filing date
VERISIGN INC COM92343E102Stock133,456$15,823,000thousands by filing date
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR750,000$12,818,000thousands by filing date
DICERNA PHARMACEUTICALS INC253031108COM1,226,820$11,728,000thousands by filing date
PRETIUM RESOURCES INC74139C102COMMON STOCK-FO1,651,328$10,998,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM92,074$10,263,000thousands by filing date
Armo Biosciences Inc04225U104COM232,115$8,683,000thousands by filing date
DENALI THERAPEUTICS INC COM24823R105Stock312,500$5,053,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001166309-18-000005this filing2018-05-15acceptance time not in the bulk data set